Christopher W Rowe (C W Rowe)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Top Venues

Diabetic medicine : a journal of the British Diabetic Association

Clinical endocrinology

BMC endocrine disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher W Rowe, Patrick Rosee, Angeline Sathiakumar, Soundarya Ramesh, Vivian Qiao, Jason Huynh, Georgia Dennien, Natasha Weaver, Katie Wynne
Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy. Diabetic medicine : a journal of the British Diabetic Association (2023)
Christopher W Rowe, Vivian Qiao, Soundarya Ramesh, Patrick Rosee, Angeline Sathiakumar, Sienna McWhae-Brown, Eliza Griffiths, Katie Wynne
Adoption of a pregnancy-specific intravenous insulin protocol (Pregnancy-IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospital. Diabetic medicine : a journal of the British Diabetic Association (2022)
Christopher W Rowe, Katie Wynne
Re: Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes - An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabetic medicine : a journal of the British Diabetic Association 39 (7) (2022)
Christopher W Rowe, Brendan Watkins, Karina Brown, Matthew Delbridge, Jordan Addley, Andrew Woods, Katie Wynne
Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association 38 (4) (2020)
Alexandra L Marlow, Christopher W Rowe, D Anderson, Katie Wynne, B R King, P Howley, Carmel E M Smart
Young children, adolescent girls and women with type 1 diabetes are more overweight and obese than reference populations, and this is associated with increased cardiovascular risk factors. Diabetic medicine : a journal of the British Diabetic Association 36 (11) (2019)
Christopher W Rowe, Sam Faulkner, Jonathan W Paul, Jorge M Tolosa, Craig Gedye, Cino Bendinelli, Katie Wynne, Shaun McGrath, John Attia, Roger Smith, Hubert Hondermarck
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis. BMC endocrine disorders 19 (1) (2019)
Christopher W Rowe, Sam Arthurs, Christine J O'Neill, Jacqueline Hawthorne, Rosemary Carroll, Katie Wynne, Cino Bendinelli
High-dose preoperative cholecalciferol to prevent post-thyroidectomy hypocalcaemia: A randomized, double-blinded placebo-controlled trial. Clinical endocrinology 90 (2) (2018)
Christopher W Rowe, E Putt, O Brentnall, A Gebuehr, J Allabyrne, A Woods, K Wynne
An intravenous insulin protocol designed for pregnancy reduces neonatal hypoglycaemia following betamethasone administration in women with gestational diabetes. Diabetic medicine : a journal of the British Diabetic Association 36 (2) (2018)
Christopher W Rowe, Cino Bendinelli, Shaun McGrath
Charting a course through the CEAs: diagnosis and management of medullary thyroid cancer. Clinical endocrinology 85 (3) (2016)